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Abstract
Background: As the demand for palliative care increases, more information is needed on how efficient different
types of palliative care models are for providing care to dying patients and their caregivers. Evidence on the
economic value of treatments and interventions is key to informing resource allocation and ultimately improving
the quality and efficiency of healthcare delivery. We assessed the available evidence on the economic value of
palliative and end-of-life care interventions across various settings.
Methods: Reviews published between 2000 and 2019 were included. We included reviews that focused on cost-
effectiveness, intervention costs and/or healthcare resource use. Two reviewers extracted data independently and in
duplicate from the included studies. Data on the key characteristics of the studies were extracted, including the aim
of the study, design, population, type of intervention and comparator, (cost-) effectiveness resource use, main
findings and conclusions.
Results: A total of 43 reviews were included in the analysis. Overall, most evidence on cost-effectiveness relates to
home-based interventions and suggests that they offer substantial savings to the health system, including a
decrease in total healthcare costs, resource use and improvement in patient and caregivers’ outcomes. The
evidence of interventions delivered across other settings was generally inconsistent.
Conclusions: Some palliative care models may contribute to dual improvement in quality of care via lower rates of
aggressive medicalization in the last phase of life accompanied by a reduction in costs. Hospital-based palliative
care interventions may improve patient outcomes, healthcare utilization and costs. There is a need for greater
consistency in reporting outcome measures, the informal costs of caring, and costs associated with hospice.
Keywords: End-of-life care, Terminal care, Palliative care, Cost - effectiveness, Health care costs
Background
In the context of increasing pressures on health budgets,
evidence on the economic value of treatments and inter-
ventions is key to informing resource allocation and
improving the quality and efficiency of healthcare deliv-
ery. As an important share of healthcare expenditures
occurs in the last months of life [1–3], a good under-
standing of the costs and benefits of care delivered dur-
ing this period is particularly important. Whether dying
patients are receiving “appropriate” care has been the
focus of recent debates [4, 5]. Notably, there are con-
cerns that many patients are admitted to the hospital
and undergo invasive procedures at the end-of-life
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without evidence of clinical benefits and improved qual-
ity of life (QoL); more than 80% of decedents are hospi-
talized at least once in the last 180 days of life in several
countries [6]. In addition, research shows that such
treatments are often counter to patient and/or caregiver
preferences [7, 8]. Palliative and end-of-life care services
and interventions have the potential to improve the
quality, appropriateness and efficiency of care provided
at the end-of-life from both the perspective of patients
and their families and the health system as a whole [9].
Palliative care has been associated with improved patient
outcomes, such as pain and symptom management [10],
improved communication [11], higher satisfaction with
care [12], improved QoL [13], reduced healthcare costs
[14, 15] and an increased likelihood of dying in one’s
preferred place [16]. Additionally, evidence suggests that
such models of care could reduce healthcare resource
use, including emergency hospital admissions, length of
hospital stays (LOS) and ICU admissions [17–19].
As the demand for palliative care services increases,
more information is needed on how effective and effi-
cient different types of palliative care models are for pro-
viding care to patients and their caregivers. In particular,
high-quality economic evidence regarding end-of-life
and palliative care interventions is crucial to adequately
support and develop new models of care that have the
potential to improve the experience of patients and their
relatives, avoid unnecessary treatments, and potentially
reduce healthcare costs. Prior research has shown that
the quality of economic evidence in the area is mixed
[20]; it is often limited to assessments of reduced health-
care utilization, without proper measurement of inter-
vention costs and/or valuation of benefits [21]. While
several reviews on the topic of palliative care have been
published in recent years, few have assessed the effect-
iveness and cost-effectiveness of palliative care interven-
tions. Existing reviews have mainly focused on particular
populations (e.g., cancer) [22], specific interventions
(e.g., advance care planning, ACP) [23], or settings (e.g.,
home-setting) [24]. A recent review of international evi-
dence provided important insights into a wide range of
palliative care models. It found that irrespective of set-
ting or patient characteristics, palliative care seem to be
beneficial to the patients and may reduce total health-
care costs [25]. However, a more detailed assessment of
effectiveness and cost-effectiveness has not been
identified.
The aim of this systematic review is to provide a com-
prehensive overview of the available evidence published
between 2000 and 2019 on the economic value of pallia-
tive and end-of-life care interventions across various set-
tings (i.e., community, home, hospital, etc.). Due to
growing evidence from multiple systematic reviews, a re-
view of reviews is considered the most appropriate
approach for bringing together the available evidence to-
gether on different interventions [26, 27].
We focused our search on published reviews that con-
tained at least some economic evidence, including mea-
sures of cost-effectiveness, intervention costs and/or
impact on healthcare use. Such knowledge might be
valuable to support health policy makers in making re-
source allocation decisions and commissioning palliative
care services.
Methods
This systematic review was performed according to PRIS
MA guidelines (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) [28]. This review is guided
by Smith et al [26] methodology for conducting system-
atic reviews of systematic reviews. This review is regis-
tered in PROSPERO (registration number:
CRD42018110910).
Search strategies
We performed systematic searches using Ovid in the fol-
lowing databases: Medline, Embase, PubMed, Cinahl,
Psychinfo, Scisearch and Cochrane. We searched reviews
published between January 2000 and September 24,
2019, using both MESH and keywords in the fields of
palliative and end-of-life care and health economics
(Table 1). Reference lists of included reviews were
screened for relevant studies. We also performed Google
Scholar searches using key search terms (‘systematic re-
view’, ‘palliative care’, ‘cost-effectiveness’).
Study selection
We included systematic reviews focusing on quantitative
assessments of intervention effectiveness that contained
economic evidence on cost-effectiveness, intervention
costs and/or resource use. We included interventions
Table 1 Search Strategy
Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-
Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) <
1946 to Present>
# Search Strategy
1 exp Terminal Care/ or exp. Palliative Care/ or exp. Terminally Ill/ or
((End adj2 life adj2 care) or EoL care or (terminal* adj2 (care or caring
or ill* or disease*)) or palliat* or dying or (Advanced adj3 (disease* or
illness*)) or end stage*).ti,ab,kf.
2 (cost: or cost benefit analys: or health care costs).mp.
3 ((exp Review Literature as Topic/ or exp. Review/ or (literature adj3
review*).ab,ti.) and ((medline or medlars or embase or pubmed or
cinahl or amed or psychlit or psyclit or psychinfo or psycinfo or
scisearch or cochrane).ab,ti. or Retracted Publication.pt.)) or Meta-
Analysis as Topic/ or Meta-analysis.pt. or (systematic* adj2 (review* or
overview)).ab,ti. or ((meta adj1 anal*) or metaanal* or metanal*).ab,ti.
4 1 and 2 and 3
5 limit 4 to (english language and yr = “2000 -Current”)
Luta et al. BMC Palliative Care           (2021) 20:89 Page 2 of 21
related to palliative and end-of-life care without restric-
tion of the setting or comparator definition. Following
Brereton et al. (2017) [25], palliative and end-of-life care
models/interventions were defined as “any structured
care model involving multiple components, including
who delivers (e.g., professionals, caregivers) the interven-
tion (specialist or generalist palliative care), where (e.g.,
hospital), to whom (care recipients), when (i.e., timing
and duration), how (e.g., face to face) and for what pur-
pose (i.e., expected outcomes).” Details on inclusion and
exclusion criteria are reported in Table 2.
Study selection
Two reviewers (BO, XL) screened independently and in
duplicate all titles and abstracts using the inclusion and
exclusion criteria (Table 1). A third reviewer (JM) pro-
vided arbitration in the event of disagreement. The same
reviewers assessed the full texts of potentially relevant
for eligibility. Any disagreement was resolved by discus-
sion and by consulting the third reviewer.
Assessment of quality of included studies
We assessed the methodological quality of included
studies using the AMSTAR. We assessed the methodo-
logical quality of included studies using the AMSTAR 2
(A Measurement Tool to Assess Reviews) which is a
critical appraisal tool for systematic reviews that include
randomized or non-randomised studies of healthcare in-
terventions, or both [29]. The reviews were rated as low,
medium quality or high quality.
Data extraction
Two authors (XL, BO) extracted data using a predefined
extraction form, and any discrepancies were resolved by
a third reviewer. Data on the key characteristics of the
studies were extracted, including information about the
aim of the review, design, population, type of interven-
tion and comparator, information on (cost) effectiveness
and resource use, and main findings and conclusions.
Data synthesis and analysis
The reviews were too heterogeneous in terms of disease,
setting and outcomes measured to perform a meta-
analysis; a narrative synthesis was considered more ap-
propriate. We organized the evidence according to the
main outcomes reported, i.e.: (1) cost-effectiveness, (2)
costs, and (3) resource use. In each section, we discuss
evidence by intervention setting and/or type.
Results
The initial searches identified 435reviews. Finally, 43 re-
view articles were included in the analysis. Figure 1 pro-
vides details on searches and study selection. Over half
of the reviews (Table 3) were published between 2011
and 2018 and included predominantly cancer patients. A
wide range of palliative and end-of-life care models were
described and comparator models were often described
as usual care, which varied across studies, or was not
specified. Most of the reviews (n = 21) involved interven-
tions delivered in multiple settings [20–23, 25, 30–50].
Nine reviews examined interventions in the hospital set-
ting [20, 50–58]. Of these, 3 focused on ICU [51–53],
and 1 on surgical patients [57]. Three reviews involved
Table 2 Inclusion and exclusion criteria
Criteria Inclusion Exclusion
Type of study Review-level (review of reviews) evidence focusing on
quantitative assessment effectiveness in palliative care
interventions.
Reviews of all types of original studies; reviews of reviews.
Not review-level evidence (primary studies).
Opinion papers, editorials, conference abstracts.
Reviews of qualitative studies.
Dates 2000–2019 Outside the date range 2000–2018
Population Reviews considering terminally ill adults (18 years old and
over) and considering patients with varying illnesses.
Reviews focusing solely on children and adolescents (under
18 years of age)
Reviews focusing on specific populations or ethnicities.
Intervention Reviews considering interventions in palliative care for any
palliative care group.
Reviews not focusing on palliative care.
Reviews focusing on a single procedure (i.e., a focus on
treatment rather than palliative care) such as
chemotherapy, radiotherapy, surgery and other curative
strategies.
Reviews focusing on palliative care, but not on
interventions.




Reviews including any information regarding costs,
whether cost, cost for caregivers cost of intervention,
hospitalization, or general costs at end-of-life.
Reviews not including quantitative cost elements.
Other outcomes Resource use –
Language Written in English. Not written in English.
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home-based interventions [24, 57, 59, 60], and 3 reviews
focused on community-based interventions [61–63].
Most of the included reviews were rated as having a
moderate quality (Table 3).
Evidence synthesis
Cost-effectiveness
In this section, we focus on studies that measured both
the costs and intervention outcomes. Ideally, these com-
ponents would be combined in an incremental cost-
effectiveness framework, following best-practice eco-
nomic evaluation guidelines [64]. Such evidence is rare
[20, 21]; therefore, the evidence shown below (Table 4)
also includes studies that measured both components in-
dependently. Overall, only 10 reviews included evidence
on cost-effectiveness of the interventions, while the
remaining 33 reviews included details on intervention
costs and/or resource use.
Home-based interventions
Overall, most cost-effectiveness evidence relates to
home-based interventions. One review [32] showed that
home-based services may reduce resource use and costs
and improve pain management and increase death out-
side the hospital.
Furthermore, home-based teams may generate sub-
stantial savings for the health system and improve pa-
tient outcomes. A review [47] identified 2 studies [65,
66] providing evidence of the cost-effectiveness of
home-based teams for specific patient groups (i.e., can-
cer AIDS). A review [59] identified 6 studies of home-
based palliative care, but only 2 of them provided clear
evidence of cost-effectiveness. Finally, various models
showed potential benefits for patients and caregivers and
reduction in total healthcare costs; most such evidence
pertains to home-based interventions [25].
Other settings
The remaining evidence relates to the cost-effectiveness
of palliative care across multiple settings [20, 21, 25, 37,
44, 54, 61]. A review on [61] palliative care interventions
outside the home, identified two studies that included an
economic evaluation [67, 68], but only one [68] per-
formed a full cost-effectiveness analysis of the effect of
psychosocial support on survival in women with breast
cancer. No significant difference in healthcare resource
use between the intervention and control groups was
Fig. 1 PRISMA flowchart
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found. Smith et al. (2014) [20] identified one cost-
effectiveness study on short-term palliative care in mul-
tiple sclerosis patients; it suggested potential cost-
effectiveness when caregiver burden was used as the
main outcome measure [69]. Salamanca et al. (2018)
[37] provided inconclusive evidence on the cost-
effectiveness of clinical nurse specialists (CNSs): of 13
economic analyses, 7 reported improvement in health
economic outcomes, mainly in cardiac patients. CNSs
were cost-effective in several countries. In Austria
home-based CNSs were both cost-effective and less
expensive than standard care for HF patients [70]. In
the United Kingdom, CNSs for heart disease patients
generated an incremental cost of £13,158 per quality-
adjusted life year (QALY) gained compared to the
control group [71]. In England CNS intervention im-
proved QoL and reduced readmissions and costs in
HF patients [72]. Similarly, a study in the Netherlands
CNSs improved health outcomes of patients with se-
vere HF, with a slight increase in costs [73]. Douglas
et al. [44] found that CNSs had lower costs and
greater benefits than comparator. A review [74] on
cost-effectiveness of pain management strategies in
advanced cancer found that PainCheck and Tackling
Cancer Pain Toolkit [TCPT] were cheaper (respective
incremental costs -GBP148 [−EUR168.53] and
-GBP474 [−EUR539.74]) and more effective (respect-
ive incremental QALYs of 0.010 and 0.013) than
usual care.
Two other reviews reported some evidence on the
benefits of hospital-based palliative care consultations on
patient outcomes, healthcare utilization and cost [54,
75]. Finally, a review by Dixon et al. (2015 [21] found no
evidence on cost-effectiveness of ACP.
Cost analyses
The following studies reported on the cost and resource
use implications of palliative care with various degrees
of comprehensiveness. Some were limited to interven-
tion cost while others compared total healthcare costs
between an intervention and a control group. Five re-
views reported the cost of home-based palliative inter-
ventions [31, 76] [24, 59, 60]. Among those, 1 [76] found
significant improvement in healthcare use or costs in 16
of 21 (76%) studies that reported those outcomes; the
majority of evidence was obtained from quasi-
experimental designs. Similarly, Gomes et al. (2013) [59]
showed lower costs for home-based group compared
with usual care (18 to 35%). Institutional and non-
institutional costs, medications costs and in 1 study, in-
formal care costs, were reported. Other reviews found
relatively low-quality and inconsistent evidence that
home-based interventions might reduce healthcare costs
[24, 60, 77], and the costs included varied across studies.
Seven reviews reported the costs of hospital-based in-
terventions [43, 51–57]. Of these, 3 focused on the ICU
[51–53], and 1 on the surgical setting [57]. Four reviews
[51, 54–56] examined the cost of inpatient palliative care
Table 4 Studies reporting on cost-effectiveness of palliative care interventions
Author Cost-effectiveness Type of intervention
Ankuda, and
Meier., 2018






Reported some evidence of cost-effectiveness of psychosocial support on survival in
women with breast cancer. No significant difference in healthcare resource use between









Hospice care interventions reduce resource use and costs, improve pain management, and
increase death outside the hospital.
Hospice care at home, nursing
homes and hospice facilities
Douglas et al.,
2003
Reported lower costs and greater benefits of CNSs compared to usual care. Evidence of









Evidence of the cost-effectiveness of home-based teams for specific patient groups includ-




Evidence from RCTs Educational and monitoring/feedback interventions have the potential




Inconclusive evidence suggesting cost-effectiveness of CNS interventions including im-
provement in health economic outcomes, mainly in cardiac patients (heart failure) in
Austria, UK and Netherlands.
Clinical nurse specialists
Smith et al., 2014 Reported one cost-effectiveness that showed short-term palliative care in multiple sclerosis
patients showed d potential cost-effectiveness when caregiver burden was used as the
main outcome measure.
Short-term palliative care
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consultations. Specifically, Kyeramateng et al. (2018)
[51] showed that palliative care consultations in the ICU
reduced LOS and costs, with 5 studies reporting a de-
crease in ICU cost and 5 others reporting a decrease in
total hospital costs. Another study [55] showed that con-
sultation delivered within 3 days of hospitalization may
reduce the costs of care, mainly in cancer and multimor-
bid patients. Similarly, in May et al. (2014) [56], consult-
ation teams were consistently found to be less costly (by
9–25% for hospital costs) compared to usual care, while
1 study estimated a 32% reduction in all healthcare costs
over 6 months post discharge. Another study [54] identi-
fied some evidence of lower costs in patients receiving
consultations. Lilley et al. (2016) [57] found limited evi-
dence regarding interventions to improve access to pal-
liative care (i.e., pain and non-pain symptoms, ACP) in
surgical patients. The evidence regarding cost implica-
tions of communication interventions was inconclusive
[52, 53].
Many studies (n = 15) reported mixed findings on the
costs of interventions in multiple settings [20, 21, 23, 25,
30–42]. Smith et al. (2014) [20] found consistent evi-
dence that palliative care is less costly relative to com-
parators, with statistically significant differences in most
cases. Four RCTs found lower costs for palliative care.
Most studies overlooked out-of-pocket and informal
care costs. Salamanca-Balen et al. 2018 [37] found mixed
evidence regarding the impact of CNS-led interventions
on costs, with 13/46 (28%) studies showing statistically
significant cost reductions and 6/46 (13%) studies show-
ing significant cost increases. Bibas et al. 2019 [78] found
one CSN-led intervention that observed a significant re-
duction in costs ($75,850 control vs $51060).
Similarly, Harris et al. (2013) [34] found statistically
significant evidence suggesting that palliative care inter-
ventions may impact healthcare costs (ranging from a
77% reduction to a 9% cost increase). Seven reviews pro-
vided inconclusive evidence regarding cost reduction for
specific interventions, including social support [61],
CNSs [44], case management [39], communication [41],
specialized palliative care [42], palliative and hospice
care teams [47], multidisciplinary palliative care inter-
ventions [79] and patient and/or caregiver QoL [38].
The evidence regarding the impact of ACP on costs is
limited. One review [21] showed savings ranging from
USD 64,827 to USD 56,700 in total healthcare costs over
6 months. Klinger et al. (2016) [23] reported net cost
savings ranging from USD 1041 to USD 64,830 per pa-
tient (relative cost reduction 68 to 5%), with the greatest
reductions found for sicker patients. Martin et al. (2016)
[62] found limited evidence of impact on costs in 1
study [80] suggesting a significant decrease in both hos-
pital costs and total healthcare costs [81]. Another study
[63] identified cost savings for patients with severe
dementia who received ACP in the community [82] and
for care home residents [80]. Another study [83] on
ACP for home health staff reported showed significant
reductions in hospitalisation rate, days and healthcare
cost.
Impact on resource use
Five studies [24, 30–32, 36, 38, 60, 76] examined the im-
pact of home-based interventions on resource use. Bain-
bridge et al. (2016) [76] showed a significant reduction
in healthcare use in the home care group. Other reviews
found inconclusive evidence regarding the impact of
home-based interventions on resource use, including
general healthcare utilization [32], LOS and hospitaliza-
tions [24, 31, 38, 60].
Candy et al. (2011) [32] showed that patients receiving
hospice care at home had lower healthcare utilization.
The strength of this evidence, however, was limited be-
cause few of the findings originated from RCTs. Davis
et al. (2015) [31] showed that early integration of out-
patient and home palliative care may reduce LOS and
hospitalizations. In another study [60], it was unclear
whether home-based care impacts hospital admissions.
Admission to hospital while receiving home-based care
varied among trials. One study [38] found that palliative
interventions (65%, 11 of 17) reduced hospital use and
that home interventions were more effective than other
interventions in cancer, COPD and dementia patients.
Evidence regarding the impact of hospital-based pallia-
tive care interventions was scarce. One review [58] sug-
gested that hospital-based palliative care may have a
positive impact on resource use (i.e., reduced hospitali-
zations). Two reviews showed a reduction in ICU LOS
for intervention patients receiving inpatient palliative
care consultations compared with control patients [50,
51]. Two other reviews found that communication inter-
ventions may decrease healthcare resource use in mul-
tiple dimensions, including duration of mechanical
ventilation [53] and hospital and ICU LOS [41, 52, 53].
Waller et al. (2017) [54] found limited evidence that
hospital-based interventions improved processes and
outcomes, with only 1 study reporting longer hospice
stays.
Nine reviews reported inconsistent findings on re-
source use across multiple settings. Three reviews found
limited evidence that palliative care interventions, in-
cluding case management [20], decreased resource use,
[20, 43, 45] and improved hospice use. The evidence on
effects of specialized palliative care is sparse, with 3 re-
views reporting fewer hospitalizations [22, 33] and
higher hospice use [42] in the intervention group. Some
evidence showed that CNS might reduce hospitaliza-
tions, rehospitalizations/admissions, and LOS [37, 44,
78]. Outpatient palliative care decreased healthcare
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utilization, including ambulatory care, physician visits,
hospitalizations, LOS and readmissions [49]. Datla et al.
(2019) [79] reported reduction in health care resource
use as a result of multi-disciplinary palliative interven-
tions in patients with symptomatic heart failure.
ACP and palliative care interventions consistently
demonstrated a trend toward decreased ICU admissions
and reduced ICU and hospital LOS [35, 83]. The mean
relative risk reduction in the percentage of admissions
with ACP and palliative care consultations was 37%.
These findings were supported by two other reviews
showing decreased hospitalization rates [62] among pa-
tients receiving ACP, including dementia patients [63].
Discussion
The strongest evidence of cost-effectiveness relates to
home-based interventions, suggesting high potential effi-
ciency gains for the health system through a decrease in
total healthcare costs and resource use and improve-
ments in patient and caregiver outcomes. The evidence
of interventions in other settings was inconsistent. There
was some evidence suggesting potential benefits of CNS
interventions for patients with heart disease. Overall, the
majority of studies focused on cancer patients. One ex-
planation is that disease trajectories for cancer are less
heterogeneous than for other diseases [80, 81] and that
the end-of-life phase is easier to predict in this patient
group [84].
Our findings reveal a potential for reduction in direct
healthcare costs and resource use mainly in home-based
programs. Inpatient palliative care consultations were
consistently associated with fewer hospitalizations, read-
missions and reduced costs. We found some evidence of
the effectiveness of ACP for reducing resource use. Such
interventions have been considered important, especially
for dementia patients [85]; however, further research is
needed regarding the effectiveness and cost-effectiveness
of ACP interventions.
Overall, most studies overlooked important costs, in-
cluding out-of-pocket, hospice and informal care costs.
It is important that future studies systematically report
these to get a comprehensive understanding of the
health economic implications of palliative and end-of-
life care, despite the complexity of their measurement
and valuation [86]. Another issue is the lack of
consistency in outcomes measurement that hinders
comparability across studies. While quality-adjusted life
years (QALYs) are widely used in cost-effectiveness, they
are limited in their ability to capture the benefits of end-
of-life and palliative care. Tools that have been devel-
oped to measure wellbeing in the broader sense should
be more widely used [87, 88]. More generally, future
economic studies in the area should more systematically
follow existing economic evaluation guidelines and
adopt a societal perspective.
Strengths and limitations
An important strength of this study is the focus on the
economic value of a wide range of interventions. The ef-
fectiveness of palliative care interventions has been stud-
ied previously, but the focus on cost-effectiveness,
resource use and costs has been scarce [25, 89]. By con-
ducting this review of reviews we believe that we have
identified the main sources of (high-quality) evidence.
This work has several limitations. One key challenge was
related to the wide range of settings and intervention
types included as well as the diversity of reporting of
findings across reviews (e.g., outcome measurement,
costing approaches, etc.). While a broad inclusion was a
deliberate feature of our study, it made the synthesis of
evidence difficult. Most approaches focused on the hos-
pital setting. Hospital costs are known to escalate in the
last phase of life, with questionable benefit to patients
[90, 91]. Furthermore, the evidence is subject to a range
of methodological limitations as discussed above. Also,
as evidence often comes from retrospective data import-
ant information (e.g., patient preferences) were not be
available [92].
Conclusions
Home-based palliative care may contribute to a dual im-
provement in quality of care by reducing aggressive
medicalization end-of-life and concomitantly reducing
costs. Hospital-based palliative care interventions may
improve patient outcomes, healthcare utilization and
costs. Evidence regarding other approaches is less con-
clusive. This study provides a foundation for discussions
between policy makers and clinical services managers re-
garding resource allocation and the commissioning of
palliative care services. There is a need for greater
consistency in costs and outcome measures reporting,
including breadth of capture (e.g., informal care costs,
hospice costs, better-suited measure of patient out-
comes, etc.). In addition, as RCTs are rarely feasible in
the area, a particular focus on the quality of observa-
tional, and quasi-experimental evidence, is warranted.
On the clinical side, further examination of who can de-
liver interventions is important for clinical practice –
can generalists (non palliative care specialists) deliver
these interventions as well as specialists? What are the
enablers and barriers to successful interventions? Also,
information on timing in relation to death would be use-
ful to understand more fully the impact and resource
implications of palliative care interventions. Research
that addresses these practical issues as well as examining
effectiveness and cost would help policy makers and
clinical teams know where to invest resources. Better
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patient care can be provided at lower costs for people in
the last phase of life with intentional palliative care
interventions.
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